Prices are closing data as of 2026-11-04, not real-time quotes. Reporting currency (CNY) differs from trading currency; multiples are converted using generation-day FX rates. Metric definitions: P/E, P/B, ROE.
Want the full AI research report for XPENG INC.?
This free page compiles public filings, financial ratios and risk screening. Generate a full research report to add business moat & competition, valuation scenarios, catalysts and bull/bear cases right at this URL.
New users who sign up free and verify their email receive 2 free credits for research reports or professional valuation.
10-Year FinancialsFY2018–2025
Financial statements are reported in CNY, while share price and market cap are quoted in USD.
Foreign private issuer in the U.S.: annual filings are Form 20-F (or 40-F) rather than domestic Form 10-K/10-Q.
Key Multi-Year Facts
- Revenue moved from CN¥9.7M in FY2018 to CN¥76.72B in FY2025 (7-year CAGR +260.4%).
- Net income was negative in FY2018, FY2019, FY2020, FY2021, FY2022, FY2023, FY2024, FY2025.
Latest 5 Fiscal Years
| Fiscal Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue (CNY B) | 21.0 | 26.9 | 30.7 | 40.9 | 76.7 |
| YoY | 259.1% | 28.0% | 14.2% | 33.2% | 87.7% |
| Net Income (CNY B) | -4.86 | -9.14 | -10.4 | -5.79 | -1.14 |
| Operating Cash Flow (CNY B) | -1.09 | -8.23 | 0.96 | -2.01 | 8.26 |
| ROE | -12.7% | -23.1% | -28.3% | -17.1% | -3.7% |
| Gross Margin | 12.5% | 11.5% | 1.5% | 14.3% | 18.9% |
| Net Margin | -23.2% | -34.0% | -33.8% | -14.2% | -1.5% |
| Debt-to-Assets | 35.8% | 48.4% | 56.8% | 62.2% | 70.6% |
Show all 8 fiscal years
| Fiscal Year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue (CNY B) | 0.01 | 2.32 | 5.84 | 21.0 | 26.9 | 30.7 | 40.9 | 76.7 |
| YoY | — | 23815.3% | 151.8% | 259.1% | 28.0% | 14.2% | 33.2% | 87.7% |
| Net Income (CNY B) | -1.40 | -3.69 | -2.73 | -4.86 | -9.14 | -10.4 | -5.79 | -1.14 |
| Operating Cash Flow (CNY B) | -1.57 | -3.56 | -0.14 | -1.09 | -8.23 | 0.96 | -2.01 | 8.26 |
| ROE | — | — | -7.9% | -12.7% | -23.1% | -28.3% | -17.1% | -3.7% |
| Gross Margin | -24.3% | -24.0% | 4.6% | 12.5% | 11.5% | 1.5% | 14.3% | 18.9% |
| Net Margin | -14411.9% | -159.0% | -46.7% | -23.2% | -34.0% | -33.8% | -14.2% | -1.5% |
| Debt-to-Assets | — | 69.1% | 23.0% | 35.8% | 48.4% | 56.8% | 62.2% | 70.6% |
Fiscal years follow the period-end calendar year (hover headers for period-end dates). ROE uses average beginning/ending equity. Source: SEC XBRL filings, compiled mechanically without AI. Official filings
Risk ChecklistAs of 2026-11-05
Rules-based screening using SEC XBRL financial data and 8-K/NT material event filings (no AI opinions).
Foreign private issuer (Form 20-F): does not file domestic Form 8-K; material filings beyond late periodic reports require Form 6-K review.
Items Flagged for Review
- Alert
-
Alert
Net LossesGoing Concern
FY2025 (2025-12-31) CN¥-1.14B, FY2024 (2024-12-31) CN¥-5.79B
FY2025 (ended 2025-12-31)
- Watch
An "Alert" or "Watch" item flags a number that merits verification in primary filings, not a sell signal.
More U.S. data: 500 largest U.S. companies · U.S. high dividend stocks · Is the stock market open today?
Compiled mechanically from public filings and market quotes (data as of 2026-11-05). For informational purposes only, not investment advice.